Cancer and aging: symposium of the 27th annual meeting of the Japanese society for biomedical gerontology, Tokyo Masanobu KitagawaMasanori UtsuyamaKatsuiku Hirokawa Review 01 December 2004 Pages: 623 - 634
A phase I/II trial of oxidized autologous tumor vaccines during the “watch and wait” phase of chronic lymphocytic leukemia David E. SpanerCaitlin HammondAndrea Deabreu Original Article 17 December 2004 Pages: 635 - 646
Local interleukin 2 therapy is most effective against cancer when injected intratumourally John J. L. JacobsDerek SparendamWillem Den Otter Original Article 01 February 2005 Pages: 647 - 654
CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes Irmela JeremiasKarsten StahnkeKlaus -Michael Debatin Original Article 10 February 2005 Pages: 655 - 662
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide Lorenz HöltlReinhold RamonerMartin Thurnher Original Article 17 December 2004 Pages: 663 - 670
Apoptosis and production of TNF-α by tumor-associated inflammatory cells in histological grade III breast cancer Farias Rogério EstevamSoares Fernando AugustoAarestrup Fernando Monteiro Original Article 30 December 2004 Pages: 671 - 676
High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells Angelika B. RiemerBrigitte HantuschErika Jensen-Jarolim Original Article 24 November 2004 Pages: 677 - 684
Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens Li LiPeter ReinhardtMichael Schmitt Original Article 31 December 2004 Pages: 685 - 693
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer Susan F. SlovinGovind RagupathiHoward I. Scher Original Article 22 February 2005 Pages: 694 - 702
Identification of a potential human telomerase reverse transcriptase–derived, HLA-A1–restricted cytotoxic T-lymphocyte epitope Marco W. J. SchreursEsther W. M. KueterErik Hooijberg Original Article 22 February 2005 Pages: 703 - 712
A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor Axel BexHenk MalloGijsbert C. de Gast Original Article 31 December 2004 Pages: 713 - 719